Abstract

Glut1, the only glucose transporter isoform expressed in the human red blood cell (RBC), binds to and is inhibited by cytochalasin B (CB). In the present study we show that incubation of RBC ghost membranes with 10 μM cytochalasin E (CE) results in a 1.8-fold increase in the number of glucose-sensitive cytochalasin B binding sites. Moreover, treatment with CE was associated with no observable change in the protein composition of RBC ghosts determined by SDS–PAGE. Removal of surface (“extrinsic”) proteins from RBC ghosts by treatment with 0.2 mM EDTA (pH 12) for 30 min resulted in a similar 1.8-fold increase in the number of glucose-sensitive CB binding sites. Western blot analysis showed that treatment with CE or EDTA resulted in no change in the amount or mobility of Glut1 present in ghost membranes. Glucose transport, measured as CB-inhibitable 3-O-[3H]methylglucose uptake by resealed ghosts, was stimulated in CE-treated resealed ghosts, with thet1/2to equilibrium decreasing from 6.8 ± 0.5 to 3.9 ± 0.3 s (P< 0.05). Treatment of ghosts with CE or EDTA followed by Western blotting of samples in the presence or absence of β-mercaptoethanol resulted in no change in immunoreactivity or mobility of the major Glut1 band. The above results suggest that a significant fraction of Glut1 transporters exists in an inactive form (“masked”) in RBC plasma membranes and that treatment of ghosts with CE or EDTA leads to an apparent activation of Glut1.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.